РЕЗУЛЬТАТЫ РОССИЙСКОГО МНОГОЦЕНТРОВОГО ИССЛЕДОВАНИЯ ЭФФЕКТИВНОСТИ И ПЕРЕНОСИМОСТИБИВАЛОСА (СТРОНЦИЯ РАНЕЛАТА) У ЖЕНЩИНС ПОСТМЕНОПАУЗАЛЬНЫМ ОСТЕОПОРОЗОМ
https://doi.org/10.14341/osteo2007324-30
Аннотация
Об авторах
L ROZhINSKAYaS ARAPOVA
L DZERANOVA
N MOLITVOSLOVOVA
E MAROVA
A ShIShKINA
N SAZONOVA
T ChERNOVA
A IL'IN
L BENEVOLENSKAYa
O NIKITINSKAYa
T KOROTKOVA
N TOROPTsOVA
A SMIRNOV
N DEMIN
S RODIONOVA
Yu BUKLEMEShEV
A ShUMSKIY
Список литературы
1. Arnaud C.D., Zanchetta J.R. et al.: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. // New England J. Medicine, 2001, Vol. 344, pp. 1434-1441
2. Black D.M., Cummings S.R., Karpf D.B., et al.: Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. // J. Lancet, 1996, Vol. 348, pp. 1535-1541;
3. Boivin G.Y., Chavassieux P.M., Santora A.C., Yates J., Meunier P.J.: Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. // J. Bone, 2000, Vol. 27, pp. 687-694
4. Bruyere O., Delmas P.D., Devogelaer J.-P. et al. Relations between increase in femoral neck bone mineral density and decrease in hip fracture incidence during treatment with strontium ranelate // Osteoporosis Int. 2006,Vol.17, suppl. 1, p.s 96. Abstracts of Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - ECCEO 6. 15-18 March, 2006, Vienna, Austria
5. Bruyere O., Roux C., Cannata J.B. et al. Associations between increase in bone mineral density and decrease in clinical vertebral fracture incidence during a treatment with strontium ranelate // Osteoporosis Int. 2006,Vol.17, suppl.1, p.s8. Abstracts of Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - ECCEO 6. 15-18 March, 2006, Vienna, Austria
6. Buehler J., Chappuis P,. Saffar J.L., Tsouderos Y., Vignery A.: Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). // J. Bone, 2001 Vol. 29, pp. 176-179
7. Chavassieux P.M., Arlot M.E., Reda C., Wei L., Yates A.J., Meunier P.J.: Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. // J. Clinical investigation, 1997, Vol. 100, pp. 1475-1480;
8. Ettinger B., Black D.M., Mitlak B.H., et al.: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treatment with raloxifene: results from a 3-year randomized clinical trial. // JAMA, 1999, Vol. 282, pp. 637-645
9. Marquis P. et al. Osteoporosis Int 2005; 16 (3):S54. Abstract P223
10. Marie P.J. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate // Osteoporosis Int. 2003, Vol.14, pp.S9-S12
11. Meunier P.J., Slosman D.O., Delmas P.D., Sebert J.L., Brandi M.L., Albanese C., Lorenc R., Pors-Nielsen S., De Vernejoul M.C., Roces A, Reginster J.Y.: Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. // J. Clinical Endocrinology and Metabolism, 2002, Vol. 87, pp. 2060-2066
12. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D., Cannata J., Balogh A., Lemmel E., Pors-Nielsen S., Rizzoli R., Genant H.K., Reginster J.: The effects of Strontium Ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. // New England J. Medicine, 2004, Vol. 350, pp. 459-468
13. Meunier P.J., Arlot M.E., Roux J.P., Portero N., Burt-Pichat B. How to rebalance bone turnover in favor of formation// Osteoporosis Int. 2006,Vol.17, suppl.1, p.s114. Abstracts of Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis - ECCEO 6. 15-18 March, 2006, Vienna, Austria
14. Neer R.M., Arnaud C.D., Zanchetta J.R., et al.: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. // New England J Medicine, 2001, Vol. 344, pp. 1434-1441
15. Reginster J.Y., Meunier P.J.: Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. // J. Osteoporosis International, 2003, Vol. 14, suppl 3, pp. S56-S65
16. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., Devogelaer J.P., Curiel M.D., Sawicki A., Goemaere S., Sorensen O.H., Felsenberg D., Meunier P.J.: Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis treatment of peripheral osteoporosis (TROPOS) study. // J. Clinical Endocrinology and Metabolism, 2005, Vol. 90, pp. 2816-2822
17. Reginster J.Y,. Sarlet N., Lejeune E., Leonori L.: Strontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of action. // J. Current Osteoporosis Rep., 2005, Vol. 1 pp. 30-34
18. Roux C., Reginster J.Y., Fechtenbaum J., Kolta S., Sawicki A., Tulssay Z., Luiserri G., Padrini J.M., Doyle D., Prince R., Fardellone P., Sorensen O.H., Meunier P.J.: Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors. // J. Bone Mineral Research, 2006, Online published January, 22 pp
19. Seeman E.: Pathogenesis of bone fragility in women and men. // J. Lancet, 2002, Vol. 359, pp. 1841-1850.
Рецензия
Для цитирования:
., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., ., . РЕЗУЛЬТАТЫ РОССИЙСКОГО МНОГОЦЕНТРОВОГО ИССЛЕДОВАНИЯ ЭФФЕКТИВНОСТИ И ПЕРЕНОСИМОСТИБИВАЛОСА (СТРОНЦИЯ РАНЕЛАТА) У ЖЕНЩИНС ПОСТМЕНОПАУЗАЛЬНЫМ ОСТЕОПОРОЗОМ. Остеопороз и остеопатии. 2007;10(3):24-30. https://doi.org/10.14341/osteo2007324-30
For citation:
ROZhINSKAYa L.Y., ARAPOVA S.D., DZERANOVA L.K., MOLITVOSLOVOVA N.N., MAROVA E.I., ShIShKINA A.A., SAZONOVA N.I., ChERNOVA T.O., IL'IN A.V., BENEVOLENSKAYa L.I., NIKITINSKAYa O.A., KOROTKOVA T.A., TOROPTsOVA N.V., SMIRNOV A.V., DEMIN N.V., RODIONOVA S.S., BUKLEMEShEV Yu.V., ShUMSKIY A.A. REZUL'TATY ROSSIYSKOGO MNOGOTsENTROVOGO ISSLEDOVANIYa EFFEKTIVNOSTI I PERENOSIMOSTIBIVALOSA (STRONTsIYa RANELATA) U ZhENShchINS POSTMENOPAUZAL'NYM OSTEOPOROZOM. Osteoporosis and Bone Diseases. 2007;10(3):24-30. (In Russ.) https://doi.org/10.14341/osteo2007324-30
Просмотров: 198
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
